F. Suzuki

发表

Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease.

M. Ochi, R. Hauser, T. Chase, 2003, Neurology.

Adenosine A2A receptor imaging with [11C]KF18446 PET in the rat brain after quinolinic acid lesion: Comparison with the dopamine receptor imaging

Keiichi Oda, Kiichi Ishiwata, Hinako Toyama, 2002, Annals of nuclear medicine.

SYNTHESIS AND PRELIMINARY EVALUATION OF 11CKF17837, A SELECTIVE ADENOSINE A2A ANTAGONIST

M. Senda, K. Oda, H. Toyama, 1996 .

Evaluation of carbon-11-labeled KF17837: a potential CNS adenosine A2a receptor ligand.

M. Senda, K. Ishiwata, T. Nariai, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Carbon-11-labeled KF21213: a highly selective ligand for mapping CNS adenosine A(2A) receptors with positron emission tomography.

M. Kiyosawa, M. Senda, K. Ishiwata, 2000, Nuclear medicine and biology.

11C-labeled KF18446: a potential central nervous system adenosine A2a receptor ligand.

M. Senda, K. Ishiwata, T. Nariai, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Restricted Rotation Involving the Tetrahedral Carbon. XIV. Conformational Equilibria and Attractive Interactions in Substituted 9-Benzyltriptycenes

F. Suzuki, M. Ōki, 1975 .

Restricted Rotation Involving the Tetrahedral Carbon. XI. Barriers to Rotation and Conformational Preferences of Substituted 9-Isopropyltriptycenes

H. Nakanishi, F. Suzuki, M. Ōki, 1974 .

Mapping adenosine A(1) receptors in the cat brain by positron emission tomography with [(11)C]MPDX.

M. Kiyosawa, M. Senda, K. Oda, 2002, Nuclear medicine and biology.

Assessment of adenosine A2A receptors with PET as a new diagnostic tool for neurological disorders

K. Ishii, J. Shimada, F. Suzuki, 2002 .

Adenosine A1 antagonists. 2. Structure-activity relationships on diuretic activities and protective effects against acute renal failure.

K. Kubo, H. Mizumoto, J. Shimada, 1992, Journal of medicinal chemistry.

Further characterization of a CNS adenosine A2a receptor ligand [11C]KF18446 within vitro autoradiography andin vivo tissue uptake

M. Senda, K. Ishiwata, K Ishiwata, 2000, Annals of nuclear medicine.

Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists.

C. Müller, M. Pawłowski, J. Sandoval-Ramírez, 1997, Journal of medicinal chemistry.

KF17837 ((E)-8-(3,4-dimethoxystyryl)-1,3-dipropyl-7-methylxanthine), a potent and selective adenosine A2 receptor antagonist.

H. Kase, J. Shimada, M. Ichimura, 1994, European journal of pharmacology.

8-(Dicyclopropylmethyl)-1,3-dipropylxanthine: a potent and selective adenosine A1 antagonist with renal protective and diuretic activities.

K. Kubo, H. Mizumoto, J. Shimada, 1991, Journal of medicinal chemistry.

Restricted Rotation Involving the Tetrahedral Carbon. VII. Rotation About the Carbon-Group IV Single Bond

H. Nakanishi, F. Suzuki, M. Ōki, 1973 .

Restricted rotation involving the tetrahedral carbon. XXV. Barriers to exchange between dl and meso forms of 9-(arylmethyl)triptycenes.

N. Nakamura, H. Kihara, F. Suzuki, 1979 .

8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors.

J. Shimada, A. Ishii, H. Nonaka, 1992, Journal of medicinal chemistry.

The naphthalene route to anthracyclinones

C. Sih, F. Suzuki, P. Corey, 1979 .

Stereospecific microbial oxidation of thioethers to sulfoxides. Application to the synthesis of R-mevalonolactone.

C. Sih, F. Suzuki, E. Abushanab, 1978 .

Medicinal Chemistry of Adenosine Receptors in Brain and Periphery

J. Shimada, F. Suzuki, 2000 .

Recent developments in selective agonists and antagonists acting at purine and pyrimidine receptors

K. Jacobson, F. Suzuki, 1996, Drug development research.

New bronchodilators. 3. Imidazo[4,5-c][1,8]naphthyridin-4(5H)-ones.

H. Kase, S. Kitamura, M. Ichimura, 1992, Journal of medicinal chemistry.

Synthesis and evaluation of 5-HT3 receptor antagonist [11C]KF17643.

M. Kiyosawa, M. Senda, K. Ishii, 1996, Nuclear medicine and biology.

Synthesis of 1H-imidazo[4,5-c]quinolin-4(5H)-one via palladium-catalyzed cyclization of N-(2-bromophenyl)-1H-imidazole-4-carboxamide

F. Suzuki, T. Kuroda, 1991 .

Regiospecific syntheses of islandicin and digitopurpone monomethyl ethers

C. Sih, F. Suzuki, R. Gleim, 1978 .

A novel synthesis and potent antiinflammatory activity of 4-hydroxy-2(1H)-oxo-1-phenyl-1,8-naphthyridine-3-carboxamides.

T. Tamura, F. Suzuki, K. Ohmori, 1992, Journal of medicinal chemistry.

Synthesis of imidazo[4,5-c]quinolin-4(5H)-one via radical cyclization

F. Suzuki, T. Kuroda, 1993 .

New bronchodilators. 1. 1,5-Substituted 1H-imidazo[4,5-c]quinolin-4(5H)-ones.

S. Kitamura, F. Suzuki, H. Manabe, 1992, Journal of medicinal chemistry.

Synthesis of (±)-3-demethoxyerythratidinone, an alkaloid of Erythrina lithosperma Blume

Y. Tsuda, M. Haruna, Kazuo Itô, 1984 .

A convenient synthesis of tricyclic purine derivatives

J. Shimada, F. Suzuki, T. Kuroda, 1993 .

Synthesis of 1, 2-Disubstituted-1-carbacephem

F. Suzuki, H. Saito, T. Hirata, 1989 .

Facile synthesis of 5,6,7,8-tetrahydropyrido[2,1-b]purin-10-one

F. Suzuki, T. Kuroda, 1993 .

5-HT3 receptor antagonists. 2. 4-Hydroxy-3-quinolinecarboxylic acid derivatives.

I. Miki, A. Ishii, F. Suzuki, 1993, Journal of medicinal chemistry.

Synthesis of anthracyclinones via base-catalyzed cyclizations of dihydroanthraquinone derivatives

C. Sih, F. Suzuki, R. Gleim, 1977 .

5-HT3 receptor antagonists. 1. New quinoline derivatives.

I. Miki, A. Ishii, F. Suzuki, 1992, Journal of medicinal chemistry.

Reactions of 6‐thiotheophylline with alkylating agents and epichlorohydrin: Isolation of S‐alkylated 6‐thiotheophylline and 7‐(2,3‐thioepoxypropyl)theophylline

H. Ueno, F. Suzuki, H. Hayashi, 1993 .

Possible physiological role of endogenous adenosine in defecation in rats.

J. Shimada, A. Ishii, F. Suzuki, 1994, European journal of pharmacology.

Synthesis of 1H‐Imidazo(4,5‐c)quinolin‐4(5H)‐one via Palladium‐ Catalyzed Cyclization of N‐(2‐Bromophenyl)‐1H‐imidazole‐4‐carboxamide.

F. Suzuki, T. Kuroda, 1992 .

KF17837: a novel selective adenosine A2A receptor antagonist with anticataleptic activity.

S. Shiozaki, T. Kanda, J. Shimada, 1994, European journal of pharmacology.

Theoretical structure-activity studies of adenosine A1 ligands: requirements for receptor affinity.

F. Suzuki, M. Kono, M. Dooley, 1996, Bioorganic & medicinal chemistry.

Neuroreceptor bindings and synaptic activity in visual system of monocularly enucleated rat.

M. Kiyosawa, M. Senda, K. Ishiwata, 2001, Japanese journal of ophthalmology.

KF 18446 PET in the rat brain after quinolinic acid lesion : Comparison with the dopamine receptor imaging

M. Senda, K. Oda, H. Toyama, 2002 .

Adenosine A1 antagonists. 3. Structure-activity relationships on amelioration against scopolamine- or N6-((R)-phenylisopropyl)adenosine-induced cognitive disturbance.

E. Fuse, S. Shiozaki, J. Shimada, 1993, Journal of medicinal chemistry.

KW‐3902, a selective high affinity antagonist for adenosine A1 receptors

H. Kase, T. Kanda, J. Shimada, 1996, British journal of pharmacology.

Adenosine A2A antagonists with potent anti-cataleptic activity

Hiroshi Kase, Joji Nakamura, Michio Ichimura, 1997 .

Total synthesis of anthracyclinones via intramolecular base-catalyzed cyclizations

C. Sih, F. Suzuki, R. Gleim, 1978 .

5-HT3 receptor antagonists. 3. Quinoline derivatives which may be effective in the therapy of irritable bowel syndrome.

A. Ishii, H. Nonaka, F. Suzuki, 1993, Journal of medicinal chemistry.

Facile Synthesis of 9H-s-Triazolo(3,4-i)purin-5(6H)-ones.

J. Shimada, F. Suzuki, 1992 .

Facile synthesis of 9H-s-triazolo-[3,4-i]purin-5-(6H)-ones

J. Shimada, F. Suzuki, 1992 .

Photoisomerization of a potent and selective adenosine A2 antagonist, (E)-1,3-Dipropyl-8-(3,4-dimethoxystyryl)-7-methylxanthine.

H. Kase, J. Shimada, N. Koike, 1993, Journal of medicinal chemistry.

(E)-1,3-dialkyl-7-methyl-8-(3,4,5-trimethoxystyryl)xanthines: potent and selective adenosine A2 antagonists.

F Suzuki, J Shimada, H Nonaka, 1992, Journal of medicinal chemistry.

1,4:3,6-Dianhydrohexitol nitrate derivatives. II. Synthesis and antianginal activity of aryl- or arylcarbonylpiperazine derivatives.

K. Kubo, F. Suzuki, A. Karasawa, 1993, Chemical & pharmaceutical bulletin.

A facile and novel synthesis of 5-phenylimidazo[4,5-c][1,8]naphthyridin-4(5H)-ones

F. Suzuki, T. Kuroda, 1991 .

Synthesis of stereoisomers of 1,4:3,6-dianhydrohexitol nitrate derivative, KF-14124

H. Ueno, F. Suzuki, H. Hayashi, 1992 .

Mapping adenosine A1 receptors in the cat brain by positron emission tomography with [11C]MPDX

Tadashi Nariai, Keiichi Oda, Kiichi Ishiwata, 2002 .

Search for PET probes for imaging the globus pallidus studied with rat brainex vivo autoradiography

Kiichi Ishiwata, Kenji Ishii, Michio Senda, 2000, Annals of nuclear medicine.

8‐(Noradamantan‐3‐yl)‐1,3‐dipropylxanthine

N. Hirayama, J. Shimada, S. Matsumiya, 1995 .